Harrow Health Stock Today
| HROW Stock | USD 10.27 0.05 0.48% |
Performance3 of 100
| Odds Of DistressLess than 39
|
Harrow Health is selling for under 10.27 as of the 24th of April 2024; that is -0.48 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.04. Harrow Health has about a 39 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Harrow Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2023 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of September 2007 | Category Healthcare | Classification Health Care |
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 35.36 M outstanding shares of which 6.12 M shares are currently shorted by private and institutional investors with about 10.56 trading days to cover. More on Harrow Health
Moving together with Harrow Stock
| 0.64 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.68 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
Moving against Harrow Stock
| 0.63 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
| 0.51 | ZURA | Zura Bio Limited Financial Report 10th of May 2024 | PairCorr |
| 0.44 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Harrow Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Harrow Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Harrow Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Mark Baum | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Harrow Health report their recommendations after researching Harrow Health's financial statements, talking to executives and customers, or listening in on Harrow Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Harrow Health. The Harrow consensus assessment is calculated by taking the average forecast from all of the analysts covering Harrow Health. | |||||
Harrow Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Harrow Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Harrow Health's financial leverage. It provides some insight into what part of Harrow Health's total assets is financed by creditors.
| |||||
Harrow Health (HROW) is traded on NASDAQ Exchange in USA. It is located in 102 Woodmont Boulevard, Nashville, TN, United States, 37205 and employs 315 people. Harrow Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 364.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Harrow Health's market, we take the total number of its shares issued and multiply it by Harrow Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Harrow Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 35.36 M outstanding shares of which 6.12 M shares are currently shorted by private and institutional investors with about 10.56 trading days to cover.
Harrow Health currently holds about 51.7 M in cash with 3.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Check Harrow Health Probability Of Bankruptcy
Ownership AllocationHarrow Health has a total of 35.36 Million outstanding shares. Over half of Harrow Health's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Harrow Health. Please watch out for any change in the institutional holdings of Harrow Health as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Harrow Ownership Details
Harrow Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Harrow Health jumping above the current price in 90 days from now is about 77.08%. The Harrow Health probability density function shows the probability of Harrow Health stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.126. This usually indicates Harrow Health market returns are correlated to returns on the market. As the market goes up or down, Harrow Health is expected to follow. Additionally, harrow Health has an alpha of 0.0844, implying that it can generate a 0.0844 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Harrow Health to move above the current price in 90 days from now is about 77.08 (This Harrow Health probability density function shows the probability of Harrow Stock to fall within a particular range of prices over 90 days) .
Harrow Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Harrow Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Harrow Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Harrow Health's value.| Instituion | Recorded On | Shares | |
| Stifel Financial Corp | 2023-12-31 | 432 K | |
| Citadel Advisors Llc | 2023-09-30 | 330.9 K | |
| Northern Trust Corp | 2023-12-31 | 316.8 K | |
| Wasatch Advisors Lp | 2023-12-31 | 302.5 K | |
| Royce & Associates, Lp | 2023-12-31 | 294.9 K | |
| Franklin Resources Inc | 2023-12-31 | 294.2 K | |
| Rice Hall James & Associates, Llc | 2023-12-31 | 231.5 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 221.8 K | |
| Westside Investment Management, Inc. | 2023-12-31 | 212.3 K | |
| Opaleye Management Inc | 2023-12-31 | 3.8 M | |
| Private Capital Management, Llc | 2023-12-31 | 2.8 M |
Harrow Health Historical Income Statement
Harrow Health Income Statement is one of the three primary financial statements used for reporting Harrow's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Harrow Health revenue and expense. Harrow Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Harrow Health's Income Tax Expense is fairly stable compared to the past year. Depreciation And Amortization is likely to climb to about 13 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (23.3 M). View More FundamentalsHarrow Stock Against Markets
Picking the right benchmark for Harrow Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Harrow Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Harrow Health is critical whether you are bullish or bearish towards Harrow Health at a given time. Please also check how Harrow Health's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Harrow Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Harrow Health Corporate Management
Elected by the shareholders, the Harrow Health's board of directors comprises two types of representatives: Harrow Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Harrow. The board's role is to monitor Harrow Health's management team and ensure that shareholders' interests are well served. Harrow Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Harrow Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert DDS | Special Advisor | Profile | |
| Jamie Webb | Director Relations | Profile | |
| Larry Dillaha | Chief Medical Officer | Profile | |
| David Moufarrge | VP Technology | Profile | |
| RPh Mannebach | Head Pharmacovigilance | Profile |
How to buy Harrow Stock?
Before investing in Harrow Health, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Harrow Health. To buy Harrow Health stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Harrow Health. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Harrow Health stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Harrow Health stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Harrow Health stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Harrow Health, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.
Already Invested in Harrow Health?
The danger of trading Harrow Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Harrow Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Harrow Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Harrow Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Harrow Health is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.75) | Revenue Per Share 3.992 | Quarterly Revenue Growth 0.788 | Return On Assets 0.0022 |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.